Install
Please login to see your bookmarks Register for free to our services and get the newsletter GTT Strategic Ventures, the investment fund of the GTT group, has completed a CHF 4.4 million funding round in novoMOF, a specialist in advanced materials for CO2 capture. This investment was made alongside Shift4Good, Regenerat
- 27articles · 30d
- 3+ day agolatest article
- Aug 14, 2026earliest in window
- 0%with images
- 256avg words
- Economy, Business & Finance 26
- Finance & Business 20
- Business & Industrial 10
- News 9
- Health & Wellness 4
- Medical 3
- Industrial 3
- Finance 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
FluoSphera powers ahead with Debiopharm and Leica Microsystems
1+ week, 4+ day ago (74+ words) Top 100 Swiss Startup Award 2024 02.09.2026 08:56 FluoSphera powers ahead with Debiopharm and Leica Microsystems 12.01.2026 16:00 FluoSphera Raises CHF 1.15M to Scale Human-Based Preclinical Platform 05.11.2024 17:00 Bio Europe in Stockholm hosts 33 Swiss companies The H1 2026 update analyses investment in Swiss start-ups during the first six months and…...
Adaptyv raises $40M to build automated lab for agentic biology
2+ week, 4+ day ago (98+ words) The founders describe the endpoint as a biological gigafactory: enough automated experimental capacity for AI to learn from physical reality as quickly as it learns from text. 26.08.2026 13:58 Adaptyv raises $40M to build automated lab for agentic biology 19.09.2025 15:00 Adaptyv leaves the beta…...
Boehringer Ingelheim acquires equine health startup Evax
4+ week, 1+ day ago (164+ words) Boehringer Ingelheim has acquired Evax AG, a Swiss biotech company focused on therapeutic vaccines to address significant unmet needs in horses, particularly for the treatment of allergic skin diseases. “We’re excited to have the potential to offer horse owners the…...
Biotech and more
4+ week, 1+ day ago (283+ words) Although biotech start-ups stand out with their mega-investments, there are numerous successful start-ups in the life sciences sector centred around pharmaceuticals. Vaderis Therapeutics, which focuses on developing targeted therapies for rare vascular diseases, has closed a USD 152 million series B…...